Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 24, 2009 - Issue 5
Submit an article Journal homepage
871
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives

Vivek KumarChemical Research, Dabur Research Foundation, 22, Site IV, Sahibabad, Ghaziabad, 201 010, UP, IndiaCorrespondence[email protected] [email protected]
,
Alka MadaanPreclinical Research, Dabur Research Foundation, 22, Site IV, Sahibabad, Ghaziabad, 201 010, UP, India
,
Vinod K. SannaPreclinical Research, Dabur Research Foundation, 22, Site IV, Sahibabad, Ghaziabad, 201 010, UP, India
,
Manupriya VishnoiPreclinical Research, Dabur Research Foundation, 22, Site IV, Sahibabad, Ghaziabad, 201 010, UP, India
,
Narendra JoshiChemical Research, Dabur Research Foundation, 22, Site IV, Sahibabad, Ghaziabad, 201 010, UP, India
,
Anu T. SinghPreclinical Research, Dabur Research Foundation, 22, Site IV, Sahibabad, Ghaziabad, 201 010, UP, India
,
Manu JaggiPreclinical Research, Dabur Research Foundation, 22, Site IV, Sahibabad, Ghaziabad, 201 010, UP, India
,
Pramod K. SharmaInstitute of Pharmacy, Bundelkhand University, Jhansi
,
Raghuveer IrchhaiyaInstitute of Pharmacy, Bundelkhand University, Jhansi
&
Anand C. Burman
 show all
Pages 1169-1178 | Received 27 Aug 2008, Accepted 12 Nov 2008, Published online: 21 Apr 2009

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mwadham M. Kabanda & Eno E. Ebenso. (2014) MP2, DFT and DFT-D study of the dimers of diazanaphthalenes: a comparative study of their structures, stabilisation and binding energies. Molecular Simulation 40:14, pages 1131-1146.
Read now
Anshumali Awasthi, Mohtashim Lohani, Manoj K. Singh, Anu T. Singh & Manu Jaggi. (2014) Pharmacokinetic evaluation of C-3 modified 1,8-naphthyridine-3-carboxamide derivatives with potent anticancer activity: lead finding. Journal of Enzyme Inhibition and Medicinal Chemistry 29:5, pages 710-721.
Read now

Articles from other publishers (7)

Govindaraj Sabarees, Vadivel Velmurugan & Viswas Raja Solomon. (2023) Discovery of new naphthyridine hybrids against enoyl-ACP reductase (inhA) protein target of Mycobacterium tuberculosis: Molecular docking, molecular dynamics simulations studies. Chemical Physics Impact 7, pages 100399.
Crossref
Salman Alrokayan, Tajamul Hussain, Salman Alamery, Arif Ahmed Mohammed, Abid Mahmood, Syeda Abida Ejaz, Peter Langer & Jamshed Iqbal. (2023) [1, 8]-Naphthyridine derivatives as dual inhibitor of alkaline phosphatase and carbonic anhydrase. BMC Chemistry 17:1.
Crossref
Madhwi Ojha, Divya Yadav, Avinash Kumar, Suman Dasgupta & Rakesh Yadav. (2021) 1,8-Naphthyridine Derivatives: A Privileged Scaffold for Versatile Biological Activities. Mini-Reviews in Medicinal Chemistry 21:5, pages 586-601.
Crossref
Abeer N. Al-romaizan, Thoraya S. Jaber & Nesreen S. Ahmed. (2019) Novel 1,8-Naphthyridine Derivatives: Design, Synthesis and in vitro screening of their cytotoxic activity against MCF7 cell line. Open Chemistry 17:1, pages 943-954.
Crossref
Alka Madaan, Ritu Verma, Vivek Kumar, Anu T. Singh, Swatantra K. Jain & Manu Jaggi. (2015) 1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities. Archiv der Pharmazie 348:12, pages 837-860.
Crossref
Michael L. Kostochka, Jaroslav Zajicek, Joseph A. Fuselier, Marcus A. Etienne, Lichun Sun & David H. Coy. (2015) Novel Tandem Aldol Intramolecular Cyclization of Substituted N -Benzylpiperidine-4-one: Synthesis of Novel-Type Nitrogen 2,8-Phenanthroline Heterocycles . Journal of Heterocyclic Chemistry 52:6, pages 1723-1730.
Crossref
Alka Madaan, Vivek Kumar, Ritu Verma, Anu T. Singh, S.K. Jain & Manu Jaggi. (2013) Anti-inflammatory activity of a naphthyridine derivative (7-chloro-6-fluoro-N-(2-hydroxy-3-oxo-1-phenyl-3-(phenylamino)propyl)-4-oxo-1-(prop-2-yn-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide) possessing in vitro anticancer potential. International Immunopharmacology 15:3, pages 606-613.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.